Pew Charitable Trusts is adding data from drugmaker Novartis’ now-defunct antibiotics research programs to its open source information-sharing platform in an effort to jump-start development of products to combat antimicrobial-resistant pathogens.
In the wake of the Blue Wave, progressive Democratic legislators are making headway in airing a single-payer policy proposal before key House committees.
John Hopkins Medicine has removed three more senior administrators at Johns Hopkins All Children’s Hospital in St. Petersburg, Fla., after reported increases in the hospital’s death rates for pediatric heart surgeries.
The Democratic attorneys general who stepped in to defend the Affordable Care Act against a lawsuit to overturn the law lodged their appeal of a decision declaring the individual mandate unconstitutional.
Bristol-Myers Squibb is spending $74 billion on fellow drugmaker Celgene in a deal aimed at stocking the combined company’s development pipeline with cancer, immunology and cardiovascular treatments.
CityMD, the fast-growing urgent care chain, has reached a contract to remain in the network of UnitedHealthcare, the country’s largest health insurer, just before the companies’ agreement was set to expire at the end of the year.
Beaumont Health has confirmed it has sold a majority share and transfer operations of its seven-county home health and hospice agency to Alternate Solutions Health Network, a Kettering, Ohio-based for-profit home health company.
The combination will bring new addiction treatment centers to New Jersey as well as the first urgent-care centers in the state to offer on-site behavioral health services.
After nearly two decades of concerted efforts, it’s time for the National Academies to judge whether quality and safety have improved and where new work is needed most.
Two health insurance lobbying groups warned that the Trump administration’s proposal to expand tax-free health reimbursement arrangements could cause higher premiums in the individual market.